NCT03996005

MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer

Evaluation of an Alternative Treatment of Localized Prostate Cancer by Guided MRI Transurtral Ultrasound With 1-year Control of the Absence of Cancer

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: University Hospital, Strasbourg, France · Academic / Other
• Sex: Male
• Age: 80 Years
• Healthy volunteers: Not accepted

Summary

Primary purpose : Evaluation of the efficiency and safety of an alternative global prostate treatment in localized prostate cancer. Primary Objective: Absence of clinically significant cancer (CSC) on control biopsy at 1-year follow-up. Secondary Objectives: 1. Biochemical response 2. Presence of any CSC on biopsy at 1- and 2-year follow-up 3. Radical treatment free survival 4. Adverse events, clinical tolerance 5. Urinary continence 6. Erectile function 7. Quality of life

Conditions

• MRI Guided Transurethral Ultrasound Ablation
• Localized Prostate Cancer
• Ablation Therapy

Interventions

Type	Name	Description
PROCEDURE	Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue	Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue

Timeline

• Start date: 2019-09-24
• Primary completion: 2023-07-25
• Completion: 2023-07-25
• First posted: 2019-06-24
• Last updated: 2026-01-08
• Results posted: 2026-01-08

Locations

1 site across 1 country: France